Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03208894
Other study ID # TTN
Secondary ID
Status Completed
Phase Phase 3
First received July 1, 2017
Last updated July 5, 2017
Start date November 1, 2016
Est. completion date June 30, 2017

Study information

Verified date July 2017
Source Armed Forces Hospital, Pakistan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date June 30, 2017
Est. primary completion date May 30, 2017
Accepts healthy volunteers No
Gender All
Age group N/A to 7 Days
Eligibility Inclusion Criteria:

- all newborn babies with clinically diagnosed TTN

Exclusion Criteria:

- babies less than 34 weeks babies with congenital malformations and CHD

Study Design


Related Conditions & MeSH terms

  • Tachypnea
  • Transient Tachypnea of the Newborn

Intervention

Drug:
Furosemide Injection
efficacy of salbutamol and furosemide in TTN

Locations

Country Name City State
Pakistan Department of Pediatrics Rawalpindi Punjab
Pakistan Military Hospital Rawalpindi Punjab

Sponsors (1)

Lead Sponsor Collaborator
Armed Forces Hospital, Pakistan

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary duration of oxygen requiremment in neonates having TTN. neonates will be subjected to treatment with furosemide and sabutamol and the duration of oxygen dependecy will be assessed. upto 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT01206946 - Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants Phase 2
Completed NCT01310153 - Effect of Supine or Prone Position After Caesarean Birth N/A
Active, not recruiting NCT04780412 - Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section Phase 3
Completed NCT01517958 - Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates N/A
Withdrawn NCT03499418 - Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Neonates
Completed NCT01859533 - Positive End Expiratory Pressure With A T-piece Resuscitator For Near-Term and Term Infants With Respiratory Distress Phase 2
Recruiting NCT01858129 - Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn Phase 2
Completed NCT01772381 - Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean Section in Term Fetus N/A
Completed NCT01225029 - Fluid Management in Transient Tachypnea of the Newborn N/A
Recruiting NCT01270581 - High Flow Nasal Cannula Versus Bubble Nasal CPAP for the Treatment of Transient Tachypnea of the Newborn in Infants ≥ 35 Weeks Gestation N/A
Recruiting NCT06278415 - Physiologically Based Cord Clamping To Improve Neonatal Outcomes After Elective Cesarean Delivery N/A
Not yet recruiting NCT06200519 - Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
Completed NCT02965365 - PATET Ratio to Rule Out Transient Tachypnea of the Newborn N/A
Recruiting NCT05538780 - Diagnosis of Transient Tachypnea of Newborn
Completed NCT04722016 - LUNG ULTRASONOGRAPHY DECREASES RADIATION EXPOSURE
Recruiting NCT06270823 - Reducing Respiratory Distress After Elective Caesarean Birth Through Knee-chest-flexion: a Randomized Controlled Trial N/A
Completed NCT03006354 - nHFOV Versus nCPAP in Transient Tachypnea of the Newborn N/A
Completed NCT05006235 - Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN) Phase 1
Recruiting NCT03346343 - Pulmonary Function Using Non-invasive Forced Oscillometry N/A
Completed NCT03165305 - The Role of Sustained Inflation on Short Term Respiratory Outcomes in Term Infants N/A